Product Images Insulin Glargine
View Photos of Packaging, Labels & Appearance
- Glucose-Lowering Effect Over 24 Hours in Patients with Type 1 Diabetes - image 01
- Step 1 - image 02
- Step 2 - image 03
- Step 3 - image 04
- Step 4 - image 05
- Step 5 - image 06
- Step 7 - image 07
- Step 8 - image 08
- Places to inject - image 09
- Get to know your pen - image 10
- Figure a - image 11
- Figure b - image 12
- Figure c - image 13
- Figure d - image 14
- Figure e - image 15
- Figure f - image 16
- Figure g - image 17
- Figure h - image 18
- Figure i - image 19
- Figure j - image 20
- Figure k - image 21
- Figure l - image 22
- Figure m - image 23
- Figure n - image 24
- Figure o - image 25
- Figure p - image 26
- Figure q - image 27
- Figure r - image 28
- Figure s - image 29
- Figure t - image 30
- Figure u - image 31
- Figure v - image 32
- Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Pen - image 33
- Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Vial - image 34
Product Label Images
The following 34 images provide visual information about the product associated with Insulin Glargine NDC 83257-015 by Biocon Biologics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Glucose-Lowering Effect Over 24 Hours in Patients with Type 1 Diabetes - image 01
Step 1 - image 02
Step 2 - image 03
Step 3 - image 04
Step 4 - image 05
Step 5 - image 06
Step 7 - image 07
Step 8 - image 08
Places to inject - image 09
Upper arms: This refers to the area of the arms above the elbows. It includes the biceps and triceps muscles and is a common target for exercise and muscle development. Front and side of thigh: This refers to the areas of the leg that are located at the front and side, specifically the quadriceps muscles in the front and the hamstrings and adductors on the sides. These muscle groups are important for leg strength and stability.*
Get to know your pen - image 10
This document appears to be describing a pen cartridge pen used for injections. It includes information about the expiration date, dose measurement, and injection process. The pen features a cap holder, body, pointer, and button for administering the dose. There is also a rubber seal and a window selector for selecting the desired insulin dose. Please note that the pen needle is not included.*
Figure a - image 11
Figure b - image 12
Figure c - image 13
Figure d - image 14
Figure e - image 15
Figure f - image 16
Figure g - image 17
Figure h - image 18
Figure i - image 19
Figure j - image 20
Figure k - image 21
Figure l - image 22
Figure m - image 23
Figure n - image 24
Figure o - image 25
Figure p - image 26
Figure q - image 27
Figure r - image 28
Figure s - image 29
Figure t - image 30
Figure u - image 31
Figure v - image 32
Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Pen - image 33
Insulin Glargine-yfgn Injection, 100 units/mL (U-100) - Vial - image 34
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
